CorporateHow Glenmark’s AbbVie Deal is a Masterclass in Indian Pharma's R&D AmbitionsBY Vaibhavi Ranjan
MarketsGlenmark Pharma Shares Surge 10% On Arm’s Landmark Deal with AbbVie For Cancer DrugBY Outlook Business Desk
CorporateSanofi Calls Report of Insulin Brand Divestment "Unfounded, Incorrect"BY Outlook Business Desk
NewsGlenmark Inks Licensing Pact With Jiangsu Alphamab, 3D Medicines For Cancer DrugBY Press Trust of India
FeatureWill Glenmark’s COVID-19 drug give it a new lease of life or just a short energy boost?BY Shruti Venkatesh
